SPP1/Osteopontin in Oncology: A Multifaceted Player in Tumor Progression
DOI:
https://doi.org/10.18063/apm.v10i2.865Keywords:
Secreted phosphoprotein 1, Tumor microenvironment, Prognostic marker, OsteopontinAbstract
Secreted Phosphoprotein 1 (SPP1), also known as Osteopontin (OPN), is a multifunctional glycoprotein widely involved in biological processes such as cell adhesion, migration, signal transduction, and immune regulation. Studies have shown that SPP1 is highly expressed in various tumors and is closely associated with tumor invasion, metastasis, and poor prognosis. Additionally, SPP1 can help tumor cells evade immune surveillance by regulating the function of immune cells in the tumor microenvironment. This article reviews the research progress of SPP1 in tumors from three aspects: first, the molecular biological characteristics of SPP1; second, the clinical value of SPP1 as a prognostic marker in various tumors, analyzing the correlation between its expression levels and patient prognosis; and finally, the mechanisms of SPP1 in the tumor microenvironment. Through this review, we aim to provide a theoretical foundation for a deeper understanding of the role of SPP1 in tumor development and to offer new insights and directions for developing SPP1-based tumor diagnostic markers and targeted therapeutic strategies.
References
Fatherazi S, Matsa-Dunn D, Foster BL, et al., 2009, Phosphate Regulates Osteopontin Gene Transcription. Journal of Dental Research, 88(1): 39–44.
Denhardt DT, Guo X, 1993, Osteopontin: A Protein With Diverse Functions. FASEB Journal, 7(15): 1475–1482.
Kaleta B, 2019, The Role of Osteopontin in Kidney Diseases. Inflammation Research, 68(2): 93–102.
Wei R, Wong JPC, Kwok HF, 2017, Osteopontin - A Promising Biomarker for Cancer Therapy. Journal of Cancer, 8(12): 2173–2183.
Yan Z, Hu X, Tang B, et al., 2023, Role of Osteopontin in Cancer Development and Treatment. Heliyon, 9(10): e21055.
He B, Mirza M, Weber GF, 2006, An Osteopontin Splice Variant Induces Anchorage Independence in Human Breast Cancer Cells. Oncogene, 25: 2192–2202.
Huang RH, Quan YJ, Chen JH, et al., 2017, Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by Activating the p38 MAPK Signaling Pathway. Cellular Physiology and Biochemistry, 41: 1851–1864.
Urtasun R, Lopategi A, George J, et al., 2012, Osteopontin, an Oxidant Stress Sensitive Cytokine, Up-Regulates Collagen-I via Integrin α(V)β(3) Engagement and PI3K/pAkt/NFκB Signaling. Hepatology, 55: 594–608.
Castello LM, Raineri D, Salmi L, et al., 2017, Osteopontin at the Crossroads of Inflammation and Tumor Progression. Mediators of Inflammation, 2017: 4049098.
Li X, Zhao S, Bian X, et al., 2022, Signatures of EMT, Immunosuppression, and Inflammation in Primary and Recurrent Human Cutaneous Squamous Cell Carcinoma at Single-Cell Resolution. Theranostics, 12: 7532–7549.
Liu Y, Zhang L, Ju X, et al., 2022, Single-Cell Transcriptomic Analysis Reveals Macrophage-Tumor Crosstalk in Hepatocellular Carcinoma. Frontiers in Immunology, 13: 955390.
Liu Y, Xun Z, Ma K, et al., 2023, Identification of a Tumour Immune Barrier in the HCC Microenvironment That Determines the Efficacy of Immunotherapy. Journal of Hepatology, 78(4): 770–782.
Liu Y, Zhang Q, Xing B, et al., 2022, Immune Phenotypic Linkage Between Colorectal Cancer and Liver Metastasis. Cancer Cell, 40(4): 424–437.
Kothari AN, Arffa ML, Chang V, et al., 2016, Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition. Journal of Clinical Medicine, 5(4): 39.
Zhang Z, Liu B, Lin Z, et al., 2024, SPP1 Could Be an Immunological and Prognostic Biomarker: From Pan-Cancer Comprehensive Analysis to Osteosarcoma Validation. FASEB Journal, 38(14): e23783.
Yi X, Luo L, Zhu Y, et al., 2022, SPP1 Facilitates Cell Migration and Invasion by Targeting COL11A1 in Lung Adenocarcinoma. Cancer Cell International, 22(1): 324.
Deng G, Zeng F, Su J, et al., 2020, BET Inhibitor Suppresses Melanoma Progression via the Noncanonical NF-κB/SPP1 Pathway. Theranostics, 10(25): 11428–11443.
Eun JW, Yoon JH, Ahn HR, et al., 2023, Cancer-Associated Fibroblast-Derived Secreted Phosphoprotein 1 Contributes to Resistance of Hepatocellular Carcinoma to Sorafenib and Lenvatinib. Cancer Communications, 43(4): 455–479.
Tang X, Li J, Yu B, et al., 2013, Osteopontin Splice Variants Differentially Exert Clinicopathological Features and Biological Functions in Gastric Cancer. International Journal of Biological Sciences, 9(1): 55–66.
Zhu Y, Gao XM, Yang J, et al., 2018, C-C Chemokine Receptor Type 1 Mediates Osteopontin-Promoted Metastasis in Hepatocellular Carcinoma. Cancer Science, 109(3): 710–723.
Xu J, Yi Y, Li L, et al., 2015, Osteopontin Induces Vascular Endothelial Growth Factor Expression in Articular Cartilage Through PI3K/AKT and ERK1/2 Signaling. Molecular Medicine Reports, 12(3): 4708–4712.
Klement JD, Paschall AV, Redd PS, et al., 2018, An Osteopontin/CD44 Immune Checkpoint Controls CD8+ T Cell Activation and Tumor Immune Evasion. Journal of Clinical Investigation, 128(12): 5549–5560.
Tsoumakidou M, 2023, The Advent of Immune Stimulating CAFs in Cancer. Nature Reviews Cancer, 23(4): 258–269.
Wang H, Li N, Liu Q, et al., 2023, Antiandrogen Treatment Induces Stromal Cell Reprogramming to Promote Castration Resistance in Prostate Cancer. Cancer Cell, 41(7): 1345–1362.
Rangaswami H, Bulbule A, Kundu GC, 2006, Osteopontin: Role in Cell Signaling and Cancer Progression. Trends in Cell Biology, 16(2): 79–87.
Qi J, Sun H, Zhang Y, et al., 2022, Single-Cell and Spatial Analysis Reveal Interaction of FAP+ Fibroblasts and SPP1+ Macrophages in Colorectal Cancer. Nature Communications, 13(1): 1742.
Liguori M, Solinas G, Germano G, et al., 2011, Tumor-associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma. Cancers, 3(4): 3740–3761.
Kzhyshkowska J, Shen J, Larionova I, 2024, Targeting of TAMs: Can We Be More Clever Than Cancer Cells? Cellular & Molecular Immunology, 21(12): 1376–1409.
O’Regan AW, Hayden JM, Berman JS, 2000, Osteopontin Augments CD3-Mediated Interferon-Gamma and CD40 Ligand Expression by T Cells, Which Results in IL-12 Production From Peripheral Blood Mononuclear Cells. Journal of Interferon & Cytokine Research, 20(5): 431–440.
Jiang X, Zhang X, Jiang N, et al., 2022, The Single-Cell Landscape of Cystic Echinococcosis in Different Stages Provided Insights Into Endothelial and Immune Cell Heterogeneity. Frontiers in Immunology, 13: 1067338.
Li X, Liu M, Liu H, et al., 2022, Tumor Metabolic Reprogramming in Lung Cancer Progression. Oncology Letters, 24(2): 287.
Shi X, You L, Luo RY, 2019, Glycolytic Reprogramming in Cancer Cells: PKM2 Dimer Predominance Induced by Pulsatile PFK-1 Activity. Physical Biology, 16(6): 066007.
Vincent EE, Sergushichev A, Griss T, et al., 2015, Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. Molecular Cell, 60(2): 195–207.
